Sangamo Therapeutics
SGMO
#8725
Rank
S$0.21 B
Marketcap
S$0.64
Share price
-6.45%
Change (1 day)
-75.63%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.10 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are S$0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.10 B-1.53%
2023-12-31S$0.10 B-69.65%
2022-12-31S$0.35 B-23.45%
2021-12-31S$0.46 B-19.72%
2020-12-31S$0.58 B111.41%
2019-12-31S$0.27 B-9.44%
2018-12-31S$0.30 B130.59%
2017-12-31S$0.13 B321.01%
2016-12-31S$31.4 M-10.47%
2015-12-31S$35.07 M-27.43%
2014-12-31S$48.33 M99.44%
2013-12-31S$24.23 M12.36%
2012-12-31S$21.56 M131.18%
2011-12-31S$9.32 M2.13%
2010-12-31S$9.13 M-58.44%
2009-12-31S$21.98 M23.42%
2008-12-31S$17.81 M5.09%
2007-12-31S$16.94 M56.22%
2006-12-31S$10.84 M-41.66%
2005-12-31S$18.59 M385.48%
2004-12-31S$3.83 M43.51%
2003-12-31S$2.66 M-22.35%
2002-12-31S$3.43 M-30.4%
2001-12-31S$4.93 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
S$48.04 B 44,896.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$5.98 B 5,504.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$104.34 B 97,620.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$14.25 B 13,249.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
S$54.33 B 50,781.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$147.13 B 137,690.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$2.01 B 1,790.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$100.61 B 94,122.09%๐Ÿ‡บ๐Ÿ‡ธ USA